Brokerages Set Bath & Body Works, Inc. (NYSE:BBWI) Price Target at $43.13

Bath & Body Works, Inc. (NYSE:BBWI) has received an average rating of “Moderate Buy” from the sixteen ratings firms that are currently covering the company, MarketBeat reports. Seven equities research analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company. The average 12 month price objective among analysts that have issued a report on the stock in the last year is $43.13.

Several analysts have recently weighed in on the company. Piper Sandler decreased their target price on Bath & Body Works from $47.00 to $39.00 and set a “neutral” rating for the company in a research report on Thursday, July 11th. Wells Fargo & Company lowered their price objective on shares of Bath & Body Works from $48.00 to $40.00 and set an “equal weight” rating for the company in a research report on Wednesday, July 24th. Barclays reduced their target price on shares of Bath & Body Works from $32.00 to $31.00 and set an “equal weight” rating on the stock in a research report on Thursday, August 29th. Evercore ISI lowered their price target on Bath & Body Works from $45.00 to $35.00 and set an “in-line” rating for the company in a report on Wednesday, August 28th. Finally, UBS Group reduced their price objective on Bath & Body Works from $52.00 to $38.00 and set a “neutral” rating on the stock in a report on Thursday, August 29th.

Bath & Body Works Trading Up 1.9 %

Shares of NYSE:BBWI opened at $28.92 on Wednesday. Bath & Body Works has a 12 month low of $26.20 and a 12 month high of $52.99. The company has a market capitalization of $6.34 billion, a price-to-earnings ratio of 7.00, a PEG ratio of 0.92 and a beta of 1.77. The firm’s 50-day moving average is $30.16 and its 200 day moving average is $37.42.

Bath & Body Works (NYSE:BBWI) last issued its quarterly earnings results on Wednesday, August 28th. The company reported $0.37 earnings per share for the quarter, topping the consensus estimate of $0.35 by $0.02. Bath & Body Works had a negative return on equity of 41.94% and a net margin of 12.69%. The firm had revenue of $1.53 billion for the quarter, compared to the consensus estimate of $1.54 billion. As a group, equities analysts forecast that Bath & Body Works will post 3.18 EPS for the current fiscal year.

Bath & Body Works Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, September 6th. Shareholders of record on Friday, August 23rd were paid a $0.20 dividend. The ex-dividend date was Friday, August 23rd. This represents a $0.80 annualized dividend and a yield of 2.77%. Bath & Body Works’s dividend payout ratio (DPR) is 19.37%.

Insider Transactions at Bath & Body Works

In other Bath & Body Works news, CEO Gina Boswell purchased 6,000 shares of the firm’s stock in a transaction on Wednesday, October 9th. The stock was bought at an average cost of $29.64 per share, for a total transaction of $177,840.00. Following the completion of the purchase, the chief executive officer now owns 242,987 shares in the company, valued at $7,202,134.68. This represents a 0.00 % increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Insiders own 0.27% of the company’s stock.

Institutional Inflows and Outflows

Hedge funds have recently bought and sold shares of the stock. Mitsubishi UFJ Asset Management Co. Ltd. raised its stake in Bath & Body Works by 28.1% in the 1st quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 258,617 shares of the company’s stock worth $12,936,000 after acquiring an additional 56,764 shares during the last quarter. Russell Investments Group Ltd. boosted its position in Bath & Body Works by 46.9% in the first quarter. Russell Investments Group Ltd. now owns 131,605 shares of the company’s stock valued at $6,572,000 after buying an additional 41,995 shares during the last quarter. Vanguard Group Inc. increased its holdings in Bath & Body Works by 4.2% in the 1st quarter. Vanguard Group Inc. now owns 27,398,192 shares of the company’s stock worth $1,370,458,000 after buying an additional 1,102,124 shares during the period. SG Americas Securities LLC raised its position in Bath & Body Works by 968.1% during the 1st quarter. SG Americas Securities LLC now owns 190,758 shares of the company’s stock worth $9,542,000 after buying an additional 172,898 shares during the last quarter. Finally, UniSuper Management Pty Ltd raised its position in Bath & Body Works by 576.9% during the 1st quarter. UniSuper Management Pty Ltd now owns 22,799 shares of the company’s stock worth $1,140,000 after buying an additional 19,431 shares during the last quarter. Institutional investors and hedge funds own 95.14% of the company’s stock.

Bath & Body Works Company Profile

Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.